Categories: News

Telangiectasia Treatment Now Available at Skin & Laser Dermatology Center

Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, visible blood vessels.

MCLEAN, VIRGINIA / ACCESSWIRE / January 15, 2025 / Telangiectasia refers to small, dilated blood vessels visible near the skin or mucous membranes’ surface, often appearing on the face, legs, chest, or other areas. These vessels may be red, blue, or purple. While generally harmless and commonly treated for cosmetic reasons, telangiectasia can also be associated with certain medical conditions, including rosacea, scleroderma, liver disease, and hereditary hemorrhagic telangiectasia (HHT), amongst others. Recognizing any underlying cause is essential for appropriate treatment and management.

At Skin & Laser Dermatology Center, the latest laser technologies are used to safely and effectively target telangiectasia. Laser treatment works by emitting light that is absorbed by the blood vessels, causing them to heat up, collapse, and be gradually reabsorbed by the body. The result is a clearer, more even skin tone.

“Telangiectasia can be a source of frustration for many people, but with modern laser treatments, we can significantly reduce their visibility,” said Dr. Amir Bajoghli, founder of Skin & Laser Dermatology Center. “Our goal is to help patients feel more confident in their appearance while providing safe, minimally invasive solutions with minimal downtime.”

Several laser options are available, including Pulsed Dye Laser (PDL) such as Vbeam Perfecta, Nd:YAG laser (GentleYAG), and Intense Pulsed Light (IPL). PDL is highly effective at targeting red spider veins, especially on the face, while Nd:YAG laser is often used for larger, deeper blood vessels on the legs. IPL is a broad-spectrum light treatment that can address superficial blood vessels and improve overall skin tone. The choice of treatment depends on factors like the size, depth, and location of the blood vessels, as well as the patient’s skin type.

Patients considering laser treatment for telangiectasia can expect a personalized approach at Skin & Laser Dermatology Center. A consultation will assess the severity of the condition and create a customized treatment plan. Multiple sessions may be required to achieve the best results, and ongoing sun protection is crucial to prevent new blood vessels from forming.

For more information or to schedule a consultation at the Skin & Laser Dermatology Center’s locations in McLean or Woodbridge, VA, please contact Dr. Bajoghli’s office to discuss your treatment options for telangiectasia.

About Skin & Laser Dermatology Center

Skin & Laser Dermatology Center is a premier medical and cosmetic dermatology practice with locations in McLean and Woodbridge, Virginia. Led by Dr. Amir Bajoghli, the center offers a comprehensive range of services, including treatments for skin conditions such as acne, eczema, and rosacea, as well as cosmetic procedures for brown spots, wrinkles, and facial rejuvenation. The practice is dedicated to providing the highest standard of care, utilizing the latest technologies and techniques in the field of dermatology.

Dr. Amir Bajoghli can be reached at either of his Virginia offices:

McLean:
1359 Beverly Rd., 2nd Floor
McLean, VA 22101
(703) 893-1114

Woodbridge:
2200 Opitz Blvd., Suite 100
Woodbridge, VA 22191
(703) 492-4140

Contact Information
Jill K
PR
hi@featureddoctor.com

SOURCE: Skin & Laser Dermatology Center

View the original press release on accesswire.com

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

27 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

1 hour ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

1 hour ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

1 hour ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

1 hour ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

1 hour ago